MELANOSOME PROTEIN SORTING, FOLDING & ANTIGEN PROCESSING
黑素体蛋白质排序、折叠
基本信息
- 批准号:6518598
- 负责人:
- 金额:$ 24.64万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1998
- 资助国家:美国
- 起止时间:1998-07-01 至 2004-06-30
- 项目状态:已结题
- 来源:
- 关键词:CD4 molecule CD8 molecule HeLa cells MHC class I antigen MHC class II antigen T lymphocyte affinity chromatography antigen presentation chemical binding chimeric proteins crosslink endoplasmic reticulum fluorescence microscopy glycoproteins immunoelectron microscopy melanocyte melanosomes membrane proteins molecular shape monophenol monooxygenase neoplastic cell culture for noncancer research protein binding protein folding protein transport western blottings
项目摘要
Tyrosinase and gp100 function in melanin biosynthesis and are resident
integral membrane proteins of a tissue-specific, lysosome-like organelle
called the melanosome. Failure of melanocytes to properly sort
tyrosinase or gp100 to the melanosome results in developmental and
pigment defects such as oculocutaneous albinism. Melanosomal sorting
may also affect immune responses to melanoma; tyrosinase and gp100 are
among the few human tumor-associated antigens recognized by CD4+, major
histocompatibility complex (MHC) class II-restricted T cells. The
mechanisms by which these proteins are sorted to melanosomes and the
relationship between melanosomal and MHC class II antigen sorting
pathways are poorly understood. We hypothesize that these two pathways
utilize similar intracellular sorting mechanisms and that proper sorting
is necessary for MHC class II-dependent antigen presentation. In
addition, tyrosinase is retained within the endoplasmic reticulum (ER)
and degraded by the proteasome under certain developmental conditions.
Proteasomal degradation may enhance antigen presentation by MHC class
I molecules. We hypothesize that tissue-specific activities regulate
the folding and/or assembly of tyrosinase and affect antigen processing
in melanic and non-melanic cells. The Specific Aims are: 1. To
identify melanosomal sorting determinants within tyrosinase and gp100.
Transfected cells will be analyzed morphologically for localization of
full-length molecules with targeted mutations or of chimeric proteins
containing isolated topologic domains derived from tyrosinase and gp100.
Cellular proteins that interact with identified determinants will be
characterized biochemically. 2. To characterize the determinants of
tyrosinase retention within the endoplasmic reticulum of non-melanic
cells. Cell type differences between melanic and non-melanic cells in
the ER protein folding environment and in the assembly and stoichiometry
of tyrosinase and chimeric proteins containing isolated tyrosinase
topologic domains will be determined using biochemical and genetic
criteria. 3. To determine whether sorting and folding affect tyrosinase
(and gp100) recognition by CD4+ and CD8+ T lymphocytes, respectively.
Melanosomal proteins will be colocalized with MHC molecules in melanoma
and transfected non-melanic cells. The effect of altering the protein
sorting and/or retention properties of tyrosinase and gp100 on
recognition by specific T cell clones will be determined.
酪氨酸酶和gp 100在黑色素生物合成中起作用,
组织特异性溶酶体样细胞器的膜整合蛋白
叫做黑素体。 黑色素细胞无法正确分类
酪氨酸酶或gp 100对黑素体的作用导致发育和
色素缺陷,如眼皮肤白化病。 黑素体分选
还可能影响对黑色素瘤的免疫反应;酪氨酸酶和gp 100是
在CD 4+识别的少数人肿瘤相关抗原中,主要是
组织相容性复合体(MHC)II类限制性T细胞。的
这些蛋白质被分选到黑素体中的机制,
黑素小体与MHC Ⅱ类抗原分选的关系
路径知之甚少。 我们假设这两条通路
利用类似的细胞内分选机制,
是MHC II类依赖性抗原呈递所必需的。 在
此外,酪氨酸酶保留在内质网(ER)内,
并在一定的发育条件下被蛋白酶体降解。
蛋白酶体降解可增强MHC类抗原提呈
I分子。 我们假设组织特异性活动调节
酪氨酸酶的折叠和/或组装并影响抗原加工
在黑色素细胞和非黑色素细胞中。 具体目标是:1。到
鉴定酪氨酸酶和GP 100中的黑素体分选决定因素。
将对转染的细胞进行形态学分析,以定位细胞。
具有靶向突变的全长分子或嵌合蛋白
含有衍生自酪氨酸酶和GP 100的分离的拓扑结构域。
与确定的决定簇相互作用的细胞蛋白质将被
具有生物化学特征。 2. 描述的决定因素
酪氨酸酶滞留在非黑素细胞的内质网内
细胞 黑素细胞和非黑素细胞之间的细胞类型差异
ER蛋白的折叠环境以及在组装和化学计量中
酪氨酸酶和含有分离的酪氨酸酶的嵌合蛋白
拓扑结构域将使用生物化学和遗传学方法确定,
的搜索. 3.为了确定排序和折叠是否影响酪氨酸酶
(and gp 100)分别被CD 4+和CD 8 + T淋巴细胞识别。
黑色素体蛋白将与黑色素瘤中的MHC分子共定位
和转染的非黑素细胞。 改变蛋白质的作用
酪氨酸酶和GP 100在
将确定特异性T细胞克隆的识别。
项目成果
期刊论文数量(8)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Proprotein convertase cleavage liberates a fibrillogenic fragment of a resident glycoprotein to initiate melanosome biogenesis.
- DOI:10.1083/jcb.200302072
- 发表时间:2003-05-12
- 期刊:
- 影响因子:0
- 作者:Berson JF;Theos AC;Harper DC;Tenza D;Raposo G;Marks MS
- 通讯作者:Marks MS
Distinct protein sorting and localization to premelanosomes, melanosomes, and lysosomes in pigmented melanocytic cells.
- DOI:10.1083/jcb.152.4.809
- 发表时间:2001-02-19
- 期刊:
- 影响因子:0
- 作者:Raposo G;Tenza D;Murphy DM;Berson JF;Marks MS
- 通讯作者:Marks MS
Lysosome-related organelles: a view from immunity and pigmentation.
溶酶体相关细胞器:从免疫和色素沉着的角度来看。
- DOI:10.1247/csf.27.443
- 发表时间:2002
- 期刊:
- 影响因子:1.5
- 作者:Raposo,Graça;Fevrier,Benoit;Stoorvogel,Willem;Marks,MichaelS
- 通讯作者:Marks,MichaelS
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Michael S Marks其他文献
Michael S Marks的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Michael S Marks', 18)}}的其他基金
Genetic and molecular basis for variation in human skin pigmentation
人类皮肤色素沉着变化的遗传和分子基础
- 批准号:
10394237 - 财政年份:2020
- 资助金额:
$ 24.64万 - 项目类别:
Genetic and molecular basis for variation in human skin pigmentation
人类皮肤色素沉着变化的遗传和分子基础
- 批准号:
10615919 - 财政年份:2020
- 资助金额:
$ 24.64万 - 项目类别:
Mechanisms regulating ion transport across the melanosomal membrane in health and disease
在健康和疾病中调节离子跨黑素体膜运输的机制
- 批准号:
9763909 - 财政年份:2019
- 资助金额:
$ 24.64万 - 项目类别:
Mechanisms regulating ion transport across the melanosomal membrane in health and disease
在健康和疾病中调节离子跨黑素体膜运输的机制
- 批准号:
10401826 - 财政年份:2018
- 资助金额:
$ 24.64万 - 项目类别:
Mechanisms regulating ion transport across the melanosomal membrane in health and disease
在健康和疾病中调节离子跨黑素体膜运输的机制
- 批准号:
10400351 - 财政年份:2018
- 资助金额:
$ 24.64万 - 项目类别:
Mechanisms regulating ion transport across the melanosomal membrane in health and disease
在健康和疾病中调节离子跨黑素体膜运输的机制
- 批准号:
10164721 - 财政年份:2018
- 资助金额:
$ 24.64万 - 项目类别:
Platelet granule formation and function in health and disease
血小板颗粒的形成及其在健康和疾病中的功能
- 批准号:
9055752 - 财政年份:2014
- 资助金额:
$ 24.64万 - 项目类别:
Platelet granule formation and function in health and disease
血小板颗粒的形成及其在健康和疾病中的功能
- 批准号:
8703361 - 财政年份:2014
- 资助金额:
$ 24.64万 - 项目类别:
Platelet granule formation and function in health and disease
血小板颗粒的形成及其在健康和疾病中的功能
- 批准号:
8846666 - 财政年份:2014
- 资助金额:
$ 24.64万 - 项目类别:
Platelet granule formation and function in health and disease
血小板颗粒的形成及其在健康和疾病中的功能
- 批准号:
9257459 - 财政年份:2014
- 资助金额:
$ 24.64万 - 项目类别:
相似海外基金
ROLE OF CD4/CD8 MOLECULE IN T CELL SPECIFICITY
CD4/CD8 分子在 T 细胞特异性中的作用
- 批准号:
3145834 - 财政年份:1990
- 资助金额:
$ 24.64万 - 项目类别:
ROLE OF CD4/CD8 MOLECULE IN T CELL SPECIFICITY
CD4/CD8 分子在 T 细胞特异性中的作用
- 批准号:
3145832 - 财政年份:1990
- 资助金额:
$ 24.64万 - 项目类别:
ROLE OF CD4/CD8 MOLECULE IN T CELL SPECIFICITY
CD4/CD8 分子在 T 细胞特异性中的作用
- 批准号:
3145835 - 财政年份:1990
- 资助金额:
$ 24.64万 - 项目类别:














{{item.name}}会员




